featured
Efficacy and Safety of Tafamidis Doses in Transthyretin Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Tafamidis Doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and Long-Term Extension Study
Eur. J. Heart Fail 2020 Oct 18;[EPub Ahead of Print], T Damy, P Garcia-Pavia, M Hanna, DP Judge, G Merlini, B Gundapaneni, TA Patterson, S Riley, JH Schwartz, MB Sultan, R WittelesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.